New tax-inversion rules kill proposed Allergan-Pfizer merger

The Obama administration’s latest move to curb companies from shifting their headquarters overseas to dodge taxes marks the strongest such action to date, derailing the $150-billion proposed merger between Pfizer Inc. of New York and Allergan, the longtime Southern California-based drug maker that...